Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease

Neurosci Lett. 2007 Mar 6;414(2):126-9. doi: 10.1016/j.neulet.2006.12.053. Epub 2007 Jan 11.

Abstract

Mitochondrial dysfunction occurs early in late-onset sporadic Parkinson's disease (PD), but the mitochondrial protein network mediating PD pathogenesis is largely unknown. Mutations in the mitochondrial serine-threonine kinase PINK1 have recently been shown to cause the early-onset autosomal recessive PARK6 variant of PD. We have now tested a candidate interactor protein of PINK1, the mitochondrial translation initiation factor 3 (MTIF3) for involvement in PD pathogenesis. In two independent case-control collectives, the c.798C>T polymorphism of the MTIF3 gene showed allelic association with PD, with a maximal significance of p=0.0073. An altered function of variant MTIF3 may affect the availability of mitochondrial encoded proteins, lead to oxidative stress and create vulnerability for PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Mutational Analysis
  • Eukaryotic Initiation Factors / genetics*
  • Female
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Male
  • Mitochondrial Diseases / genetics*
  • Mitochondrial Diseases / metabolism
  • Mitochondrial Diseases / physiopathology
  • Mitochondrial Proteins / genetics*
  • Mutation / genetics
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism
  • Parkinson Disease / physiopathology
  • Polymorphism, Genetic / genetics*
  • Predictive Value of Tests
  • Protein Kinases / genetics

Substances

  • Eukaryotic Initiation Factors
  • Genetic Markers
  • MTIF3 protein, human
  • Mitochondrial Proteins
  • Protein Kinases
  • PTEN-induced putative kinase